Cannabidiol Market Size by Source (Hemp, Marijuana), by Distribution Channel (B2B, B2C), End-use (Medical, Personal Use), Region (North America, Europe, Asia Pacific, and Rest of the World) - Global Forecast to 2027
The global cannabidiol market is projected to reach USD 11.9 billion by 2027 from USD 5.4 Billion in 2022, at a CAGR of 17.1% during the forecast period
To know about the assumptions considered for the study, Request for Free Sample Report
Cannabis sativa, usually referred to as cannabis or hemp, contains a substance called cannabidiol (CBD). The United States has approved one specific type of CBD as a medication for seizures. The Cannabis sativa plant contains more than 80 cannabinoids, also referred to as psychoactive substances. The component of cannabis most well known as THC is delta-9-tetrahydrocannabinol. However, hemp, a variety of the Cannabis sativa plant with very little THC present, is where CBD is obtained.
The primary factor driving the market is the increased demand for CBD for health and wellness applications due to its therapeutic characteristics. A significant element that is anticipated to increase the manufacture of CBD-infused products is the increased acceptance and use of products because of regulatory approvals.
The cannabidiol market is segmented by source, sales type, end use, and region. Based on source the market is segmented into hemp and marijuana. The market is further segmented based on sales type as business to business and business to customer. The cannabidiol market is also segmented by end use as medical, personal use, pharmaceutical, and wellness.
Based on region, the cannabidiol market is segmented into North America, Europe, Asia Pacific, and Rest of the World which includes Latin America and Middle East & Africa.
To know about the assumptions considered for the study, download the pdf brochure
Some of the major companies in the cannabidiol market are Canopy Growth Corporation (Canada), Aphria, Inc. (US), Aurora Cannabis (Canada), Maricann, Inc. (Wayland Group Corporation) (Canada), Tilray (US), GW Pharmaceuticals Plc (UK), Abcann Medicinals, Inc. (US), Organigram Holding Inc. (Canada), Tikun Olam (Israel), The Cronos Group (Canada), Endoca (US), Isodiol International, Inc. (Canda), Medical Marijuana, Inc. (US), Cannoid, LLC (US), Elixinol (Australia), Folium Biosciences (US), Nuleaf Naturals, LLC (US), and Pharmahemp D.O.O. (Slovania).
To speak to our analyst for a discussion on the above findings, click Speak to Analyst
Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.
TABLE OF CONTENTS
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS & EXCLUSIONS
1.3 MARKET SCOPE
1.3.1 MARKET COVERED
1.3.2 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 LIMITATIONS
1.6 STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.1.1 SECONDARY DATA
2.1.2 PRIMARY DATA
2.1.2.1 Key industry insights
2.2 MARKET SIZE ESTIMATION
2.3 MARKET GROWTH RATE PROJECTIONS
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
2.5 ASSUMPTIONS FOR THE STUDY
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.2 RESTRAINTS
5.2.3 OPPORTUNITIES
5.2.4 CHALLENGES
5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS
5.4 PRICING ANALYSIS
5.5 VALUE CHAIN ANALYSIS
5.6 ECOSYSTEM ANALYSIS
5.7 PATENT ANALYSIS
5.8 KEY CONFERENCES AND EVENTS IN 2022-2023
5.9 REGULATORY ANALYSIS
5.10 PORTER’S FIVE FORCES ANALYSIS
5.11 KEY STAKEHOLDER AND BUYING CRITERIA
6 CANNABIDIOL MARKET, BY SOURCE, 2020-2027 (USD MILLION)
6.1 INTRODUCTION
6.2 HEMP
6.3 MARIJUANA
7 CANNABIDIOL MARKET, BY SALES TYPE, 2020-2027 (USD MILLION)
7.1 INTRODUCTION
7.2 BUSSINESS TO BUSSINESS (B2B)
7.3 BUSINESS TO CONSUMER (B2C)
7.3.1 HOSPITAL PHARMACIES
7.3.2 ONLINE STORES
7.3.3 RETAIL STORES
8 CANNABIDIOL MARKET, BY END USE, 2020-2027 (USD MILLION)
8.1 INTRODUCTION
8.2 MEDICAL
8.2.1 CHRONIC PAIN
8.2.2 MENTAL DISORDER
8.2.3 CANCER
8.2.4 OTHERS
8.3 PERSONAL USE
8.4 PHARMACEUTICAL
8.5 WELLNESS
8.5.1 FOOD & BEVERAGES
8.5.2 PERSONAL CARE & COSMETICS
8.5.3 NUTRACEUTICALS
8.5.4 OTHERS
9 CANNABIDIOL MARKET, BY REGION, 2020-2027 (USD MILLION)
9.1 INTRODUCTION
9.2 NORTH AMERICA
9.2.1 US
9.2.2 CANADA
9.3 EUROPE
9.3.1 GERMANY
9.3.2 FRANCE
9.3.3 UK
9.3.4 ITALY
9.3.5 SPAIN
9.3.6 ROE
9.4 ASIA PACIFIC
9.4.1 JAPAN
9.4.2 CHINA
9.4.3 INDIA
9.4.4 REST OF APAC
9.5 REST OF THE WORLD (ROW)
9.5.1 LATIN AMERICA
9.5.2 MIDDLE EAST & AFRICA
10 COMPETITIVE LANDSCAPE
10.1 OVERVIEW
10.2 KEY PLAYER STRATEGIES
10.3 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS
10.4 MARKET SHARE ANALYSIS, 2021
10.5 COMPANY EVALUATION QUADRANT
10.6 COMPANY EVALUATION QUADRANT – SME/START-UPS
10.7 COMPANY GEOGRAPHIC FOOTPRINT
10.8 COMPETITIVE SCENARIO
11 COMPANY PROFILES
(The details on business overview, financial information, products/services portfolio, recent developments, MarketsandMarkets view will be provided) *
11.1 CANOPY GROWTH CORPORATION.
11.2 APHRIA, INC.
11.3 AURORA CANNABIS
11.4 MARICANN, INC. (WAYLAND GROUP CORPORATION)
11.5 TILRAY
11.6 GW PHARMACEUTICALS, PLC
11.7 ABCANN MEDICINALS, INC.
11.8 ORGANIGRAM HOLDING, INC.
11.9 TIKUN OLAM
11.10 THE CRONOS GROUP
11.11 ENDOCA
11.12 ISODIOL INTERNATIONAL, INC.
11.13 MEDICAL MARIJUANA, INC.
11.14 CANNOID, LLC
11.15 ELIXINOL
11.16 FOLIUM BIOSCIENCES
11.17 NULEAF NATURALS, LLC
11.18 PHARMAHEMP D.O.O.
* Details on business overview, financial information, products/services portfolio, recent developments, MarketsandMarkets view might not be captured in case of unlisted companies.
12 APPENDIX
12.1 INSIGHTS FROM INDUSTRY EXPERTS
12.2 DISCUSSION GUIDE
12.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
12.4 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
12.5 AVAILABLE CUSTOMIZATIONS
12.6 RELATED REPORTS
12.7 AUTHOR DETAILS
Growth opportunities and latent adjacency in Cannabidiol Market